Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice

M. Neale Weitzmann, Susanne Roser-Page, Tatyana Vikulina, Daiana Weiss, Li Hao, W. Hunter Baldwin, Kanglun Yu, Natalia del Mazo Arbona, Meghan Elizabeth McGee Lawrence, Shannon L. Meeks, Christine L. Kempton

Research output: Contribution to journalArticle

Abstract

Hemophilia A (HA), a rare X-linked recessive genetic disorder caused by insufficient blood clotting factor VIII, leaves affected individuals susceptible to spontaneous and traumatic hemorrhage. Although males generally exhibit severe symptoms, due to variable X inactivation, females can also be severely impacted. Osteoporosis is a disease of the skeleton predisposing patients to fragility fracture, a cause of significant morbidity and mortality and a common comorbidity in HA. Because the causes of osteoporosis in HA are unclear and in humans confounded by other traditional risk factors for bone loss, in this study, we phenotyped the skeletons of F8 total knockout (F8TKO) mice, an animal model of severe HA. We found that trabecular bone accretion in the axial and appendicular skeletons of male F8TKO mice lagged significantly between 2 and 6 months of age, with more modest cortical bone decline. By contrast, in female mice, diminished bone accretion was mostly limited to the cortical compartment. Interestingly, bone loss was associated with a decline in bone formation in male mice but increased bone resorption in female mice, a possible result of sex steroid insufficiency. In conclusion, our studies reveal a sexual dimorphism in the mechanism driving bone loss in male and female F8TKO mice, preventing attainment of peak bone mass and strength. If validated in humans, therapies aimed at promoting bone formation in males but suppressing bone resorption in females may be indicated to facilitate attainment of peak mass in children with HA to reduce the risk for fracture later in life.

Original languageEnglish (US)
Pages (from-to)288-300
Number of pages13
JournalBlood Advances
Volume3
Issue number3
DOIs
StatePublished - Feb 12 2019

Fingerprint

Hemophilia A
Bone Resorption
Osteogenesis
Bone and Bones
Skeleton
Knockout Mice
Osteoporosis
X Chromosome Inactivation
Inborn Genetic Diseases
Blood Coagulation Factors
Factor VIII
Blood Coagulation
Sex Characteristics
Comorbidity
Animal Models
Steroids
Hemorrhage
Morbidity
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Neale Weitzmann, M., Roser-Page, S., Vikulina, T., Weiss, D., Hao, L., Hunter Baldwin, W., ... Kempton, C. L. (2019). Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice. Blood Advances, 3(3), 288-300. https://doi.org/10.1182/bloodadvances.2018027557

Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice. / Neale Weitzmann, M.; Roser-Page, Susanne; Vikulina, Tatyana; Weiss, Daiana; Hao, Li; Hunter Baldwin, W.; Yu, Kanglun; del Mazo Arbona, Natalia; McGee Lawrence, Meghan Elizabeth; Meeks, Shannon L.; Kempton, Christine L.

In: Blood Advances, Vol. 3, No. 3, 12.02.2019, p. 288-300.

Research output: Contribution to journalArticle

Neale Weitzmann, M, Roser-Page, S, Vikulina, T, Weiss, D, Hao, L, Hunter Baldwin, W, Yu, K, del Mazo Arbona, N, McGee Lawrence, ME, Meeks, SL & Kempton, CL 2019, 'Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice', Blood Advances, vol. 3, no. 3, pp. 288-300. https://doi.org/10.1182/bloodadvances.2018027557
Neale Weitzmann M, Roser-Page S, Vikulina T, Weiss D, Hao L, Hunter Baldwin W et al. Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice. Blood Advances. 2019 Feb 12;3(3):288-300. https://doi.org/10.1182/bloodadvances.2018027557
Neale Weitzmann, M. ; Roser-Page, Susanne ; Vikulina, Tatyana ; Weiss, Daiana ; Hao, Li ; Hunter Baldwin, W. ; Yu, Kanglun ; del Mazo Arbona, Natalia ; McGee Lawrence, Meghan Elizabeth ; Meeks, Shannon L. ; Kempton, Christine L. / Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice. In: Blood Advances. 2019 ; Vol. 3, No. 3. pp. 288-300.
@article{c580d411415e4ade8bb5f8c1d30d5916,
title = "Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice",
abstract = "Hemophilia A (HA), a rare X-linked recessive genetic disorder caused by insufficient blood clotting factor VIII, leaves affected individuals susceptible to spontaneous and traumatic hemorrhage. Although males generally exhibit severe symptoms, due to variable X inactivation, females can also be severely impacted. Osteoporosis is a disease of the skeleton predisposing patients to fragility fracture, a cause of significant morbidity and mortality and a common comorbidity in HA. Because the causes of osteoporosis in HA are unclear and in humans confounded by other traditional risk factors for bone loss, in this study, we phenotyped the skeletons of F8 total knockout (F8TKO) mice, an animal model of severe HA. We found that trabecular bone accretion in the axial and appendicular skeletons of male F8TKO mice lagged significantly between 2 and 6 months of age, with more modest cortical bone decline. By contrast, in female mice, diminished bone accretion was mostly limited to the cortical compartment. Interestingly, bone loss was associated with a decline in bone formation in male mice but increased bone resorption in female mice, a possible result of sex steroid insufficiency. In conclusion, our studies reveal a sexual dimorphism in the mechanism driving bone loss in male and female F8TKO mice, preventing attainment of peak bone mass and strength. If validated in humans, therapies aimed at promoting bone formation in males but suppressing bone resorption in females may be indicated to facilitate attainment of peak mass in children with HA to reduce the risk for fracture later in life.",
author = "{Neale Weitzmann}, M. and Susanne Roser-Page and Tatyana Vikulina and Daiana Weiss and Li Hao and {Hunter Baldwin}, W. and Kanglun Yu and {del Mazo Arbona}, Natalia and {McGee Lawrence}, {Meghan Elizabeth} and Meeks, {Shannon L.} and Kempton, {Christine L.}",
year = "2019",
month = "2",
day = "12",
doi = "10.1182/bloodadvances.2018027557",
language = "English (US)",
volume = "3",
pages = "288--300",
journal = "Blood advances",
issn = "2473-9529",
publisher = "American Society of Hematology",
number = "3",

}

TY - JOUR

T1 - Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice

AU - Neale Weitzmann, M.

AU - Roser-Page, Susanne

AU - Vikulina, Tatyana

AU - Weiss, Daiana

AU - Hao, Li

AU - Hunter Baldwin, W.

AU - Yu, Kanglun

AU - del Mazo Arbona, Natalia

AU - McGee Lawrence, Meghan Elizabeth

AU - Meeks, Shannon L.

AU - Kempton, Christine L.

PY - 2019/2/12

Y1 - 2019/2/12

N2 - Hemophilia A (HA), a rare X-linked recessive genetic disorder caused by insufficient blood clotting factor VIII, leaves affected individuals susceptible to spontaneous and traumatic hemorrhage. Although males generally exhibit severe symptoms, due to variable X inactivation, females can also be severely impacted. Osteoporosis is a disease of the skeleton predisposing patients to fragility fracture, a cause of significant morbidity and mortality and a common comorbidity in HA. Because the causes of osteoporosis in HA are unclear and in humans confounded by other traditional risk factors for bone loss, in this study, we phenotyped the skeletons of F8 total knockout (F8TKO) mice, an animal model of severe HA. We found that trabecular bone accretion in the axial and appendicular skeletons of male F8TKO mice lagged significantly between 2 and 6 months of age, with more modest cortical bone decline. By contrast, in female mice, diminished bone accretion was mostly limited to the cortical compartment. Interestingly, bone loss was associated with a decline in bone formation in male mice but increased bone resorption in female mice, a possible result of sex steroid insufficiency. In conclusion, our studies reveal a sexual dimorphism in the mechanism driving bone loss in male and female F8TKO mice, preventing attainment of peak bone mass and strength. If validated in humans, therapies aimed at promoting bone formation in males but suppressing bone resorption in females may be indicated to facilitate attainment of peak mass in children with HA to reduce the risk for fracture later in life.

AB - Hemophilia A (HA), a rare X-linked recessive genetic disorder caused by insufficient blood clotting factor VIII, leaves affected individuals susceptible to spontaneous and traumatic hemorrhage. Although males generally exhibit severe symptoms, due to variable X inactivation, females can also be severely impacted. Osteoporosis is a disease of the skeleton predisposing patients to fragility fracture, a cause of significant morbidity and mortality and a common comorbidity in HA. Because the causes of osteoporosis in HA are unclear and in humans confounded by other traditional risk factors for bone loss, in this study, we phenotyped the skeletons of F8 total knockout (F8TKO) mice, an animal model of severe HA. We found that trabecular bone accretion in the axial and appendicular skeletons of male F8TKO mice lagged significantly between 2 and 6 months of age, with more modest cortical bone decline. By contrast, in female mice, diminished bone accretion was mostly limited to the cortical compartment. Interestingly, bone loss was associated with a decline in bone formation in male mice but increased bone resorption in female mice, a possible result of sex steroid insufficiency. In conclusion, our studies reveal a sexual dimorphism in the mechanism driving bone loss in male and female F8TKO mice, preventing attainment of peak bone mass and strength. If validated in humans, therapies aimed at promoting bone formation in males but suppressing bone resorption in females may be indicated to facilitate attainment of peak mass in children with HA to reduce the risk for fracture later in life.

UR - http://www.scopus.com/inward/record.url?scp=85060961072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060961072&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2018027557

DO - 10.1182/bloodadvances.2018027557

M3 - Article

VL - 3

SP - 288

EP - 300

JO - Blood advances

JF - Blood advances

SN - 2473-9529

IS - 3

ER -